Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sun, S.-S.
Right arrow Articles by Lee, C.-C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sun, S.-S.
Right arrow Articles by Lee, C.-C.
Related Collections
Right arrow Diagnostics and Imaging Procedures
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 1106-1111
© 2001 British Society for Rheumatology


Original Papers

The role of technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus patients with non-specific chest complaints

S.-S. Sun, Y.-C. Shiau1, S.-C. Tsai2, C.-C. Lin3, A. Kao4, and C.-C. Lee4

Departments of Nuclear Medicine,
3 Family Medicine and
4 Medical Research, China Medicine College Hospital, Taichung,
1 Department of Nuclear Medicine, Far Eastern Memorial Hospital and Institute of Biomedical Engineering, College of Electrical Engineering, National Taiwan University, Taipei and
2 Department of Nuclear Medicine, Show-Chwan Memorial Hospital, Chunghua, Taiwan

Objectives. Systemic lupus erythematosus (SLE) can affect multiple organs. Coronary artery disease has received increasing recognition as a major cause of morbidity and mortality in SLE in recent years. The purpose of this study was to evaluate the utility of technetium-99m sestamibi single-photon emission computed tomography (99mTc-sestamibi SPECT) in the detection of cardiovascular involvement in SLE patients with non-specific clinical chest symptoms such as chest discomfort and/or dyspnoea and/or occasional palpitation.

Methods. Thirty-three SLE female patients (age range: 22–45 yr) with non-specific complaints such as chest discomfort and/or dyspnoea and/or occasional palpitation were investigated using a 99mTc-sestamibi myocardial perfusion SPECT scan at rest and after dipyridamole infusion in a stress study. The age- and sex-matched healthy group (24 cases) and SLE patients without any cardiovascular symptoms/signs (28 cases) were also included as controls in this study. The results of the uptake pattern of 99mTc-sestamibi were classified into four types including normal, persistent perfusion defect, reversible perfusion defect and reverse redistribution.

Results. Perfusion abnormalities were detected in 27 cases (seven patients had persistent perfusion defects, 15 patients had reversible perfusion defects, one patient had both persistent and reversible perfusion defects, two patients showed a reverse redistribution pattern and two patients had both reversible perfusion defects and a reverse redistribution pattern). The results of the SPECT in the healthy group were all normal. However, perfusion abnormalities were detected in 12 cases in the group of asymptomatic SLE patients.

Conclusions99mTc-sestamibi myocardial perfusion SPECT is a useful non-invasive imaging modality to detect cardiovascular involvement in SLE patients with non-specific clinical complaints of heart disease.

KEY WORDS: 99mTc-sestamibi SPECT, Systemic lupus erythematosus, Coronary artery disease.

Correspondence to: A. Kao, Departments of Nuclear Medicine and Medical Research, China Medical College Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
M. Garcia-Carrasco, R.O. Escarcega, J. Perez-Terron, A. Ramirez, M. Munoz-Guarneros, A. Beltran, B. Perez-Cuevas, A. Lopez-Colombo, and R. Cervera
Lack of subclinical myocardial ischaemia in Mexican patients with systemic lupus erythematosus without traditional risk factors for coronary artery disease
Lupus, April 1, 2007; 16(4): 298 - 301.
[Abstract] [PDF]


Home page
LupusHome page
M Haubitz
Exploring new territory: the move towards individualised treatment
Lupus, March 1, 2007; 16(3): 227 - 231.
[Abstract] [PDF]


Home page
LupusHome page
Z Szekanecz and Y Shoenfeld
Lupus and cardiovascular disease: the facts
Lupus, November 1, 2006; 15(11_suppl): 3 - 10.
[Abstract] [PDF]


Home page
CirculationHome page
Y. Shoenfeld, R. Gerli, A. Doria, E. Matsuura, M. M. Cerinic, N. Ronda, L. J. Jara, M. Abu-Shakra, P. L. Meroni, and Y. Sherer
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Circulation, November 22, 2005; 112(21): 3337 - 3347.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Schattner and M. H. Liang
The Cardiovascular Burden of Lupus: A Complex Challenge
Arch Intern Med, July 14, 2003; 163(13): 1507 - 1510.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.